Biotech & pharma
Study of giant viruses shakes up tree of life
17 Sep 2012
Tracking stem cell reprogramming
By By Anne Trafton, MIT News Office | 17 Sep 2012
Probing matters of the heart
By By Anne Trafton | 15 Sep 2012
Deciphering the language of transcription factors
By By Larry Hardesty, MIT News Office | 13 Sep 2012
Genes that suppress tumours vital to regulating blood precursor cells: study
By By Kim Irwin | 12 Sep 2012
Weapon-wielding marine microbes may protect populations from foes
By By Denise Brehm, Civil and Environmental Engineeri | 12 Sep 2012
In some populations, natural antibiotics are produced by a few individuals whose closest relatives carry genes conferring resistance.
Discovery makes sense of molybdenum mystery
By By Quinn Phillips | 10 Sep 2012
Yale team finds fossil DNA not dead in human genome
By By Bill Hathaway | 07 Sep 2012
Yale researchers using sophisticated data mining and statistical models have discovered that many pseudogenes — stretches of fossil DN — may not be quite dead after all
Researchers identify biochemical functions for most of the human genome
By By Anne Trafton, MIT News Office | 06 Sep 2012
Only about 1 per cent of the human genome contains gene regions that code for proteins, raising the question of what the rest of the DNA is doing. Scientists have now begun to discover the answer
Binding sites for LIN28 protein found in thousands of human genes
By By Debra Kain | 05 Sep 2012
Zooming in on bacterial weapons in 3D
03 Sep 2012
Ancient genome reveals its secrets
31 Aug 2012
More sophisticated wiring, not just a bigger brain, helped humans evolve beyond chimps
By By Elaine Schmidt | 29 Aug 2012
Turning on key enzyme blocks tumour formation
By By Anne Trafton, MIT News Office | 28 Aug 2012
New nanoparticles shrink tumours in mice
By By Anne Trafton, News Office | 17 Aug 2012
Particles that shut off cancer genes could also allow researchers to screen potential drug targets more rapidly
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
